Orphan Drugs: Costs
Interactive Video
•
Health Sciences, Social Studies, Biology
•
University
•
Hard
Wayground Content
FREE Resource
The video discusses the Orphan Drug Act, highlighting its economic impact and market exclusivity benefits. It examines specific cases like Pomalyst and 3,4-DAP, analyzing their pricing and market dynamics. The cost-effectiveness of orphan drugs is evaluated, considering the willingness to pay for quality-adjusted life years (QALYs). The video also covers FDA approvals and the influence of the Orphan Drug Act on drug development. It concludes with a call for viewer support through Patreon.
Read more
2 questions
Show all answers
1.
OPEN ENDED QUESTION
3 mins • 1 pt
Discuss the potential benefits and drawbacks of the Orphan Drug Act as mentioned in the text.
Evaluate responses using AI:
OFF
2.
OPEN ENDED QUESTION
3 mins • 1 pt
What are the implications of drug manufacturers gaming the Orphan Drug Act?
Evaluate responses using AI:
OFF
Access all questions and much more by creating a free account
Create resources
Host any resource
Get auto-graded reports
Continue with Google
Continue with Email
Continue with Classlink
Continue with Clever
or continue with
Microsoft
%20(1).png)
Apple
Others
Already have an account?
